CDK8 and neoplasm: Inhibiting the activity of mediator kinase (CDK8/19) in acute myeloid leukemia can upregulate the SE activity related to a tumor suppressor and activate the expression of the tumor suppressor gene, thus achieving anti-leukemia activity (Pelish et al., 2015).